$GEVO
Gevo, Inc.

2017 Q4 Form 10-K Financial Statement

#000156459018006978 Filed on March 28, 2018

View on sec.gov

Income Statement

Concept 2017 Q4 2017 2016 Q4
Revenue $6.680M $27.54M $5.840M
YoY Change 14.38% 1.19% -20.0%
Cost Of Revenue $9.340M $38.17M $8.160M
YoY Change 14.46% 3.1% -9.33%
Gross Profit -$2.660M -$10.63M -$2.320M
YoY Change 14.66% 8.41% 36.47%
Gross Profit Margin -39.82% -38.6% -39.73%
Selling, General & Admin $1.280M $7.471M $2.630M
YoY Change -51.33% -16.66% -20.06%
% of Gross Profit
Research & Development $860.0K $5.182M $1.550M
YoY Change -44.52% -0.65% -3.13%
% of Gross Profit
Depreciation & Amortization $1.650M $6.640M $1.710M
YoY Change -3.51% -1.63% 2.4%
% of Gross Profit
Operating Expenses $2.150M $12.65M $4.170M
YoY Change -48.44% -10.77% -14.55%
Operating Profit -$4.810M -$23.28M -$6.490M
YoY Change -25.89% -2.93% -1.37%
Interest Expense $430.0K $2.951M $4.610M
YoY Change -90.67% -62.35% -381.1%
% of Operating Profit
Other Income/Expense, Net $0.00 -$1.348M $10.00K
YoY Change -100.0% -89.82% 0.0%
Pretax Income -$4.390M -$24.63M -$2.290M
YoY Change 91.7% -33.84% -71.23%
Income Tax
% Of Pretax Income
Net Earnings -$4.390M -$24.63M -$2.290M
YoY Change 91.7% -33.84% -71.23%
Net Earnings / Revenue -65.72% -89.45% -39.21%
Basic Earnings Per Share
Diluted Earnings Per Share -$4.065M -$30.41M -$329.5K
COMMON SHARES
Basic Shares Outstanding 136.4M
Diluted Shares Outstanding

Balance Sheet

Concept 2017 Q4 2017 2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.60M $11.60M $27.90M
YoY Change -58.42% -58.42% 64.12%
Cash & Equivalents $11.55M $11.60M $30.50M
Short-Term Investments
Other Short-Term Assets $700.0K $700.0K $900.0K
YoY Change -22.22% -22.22% 28.57%
Inventory $4.362M $4.400M $3.500M
Prepaid Expenses $639.0K
Receivables $1.054M $1.100M $1.100M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $17.68M $17.70M $33.30M
YoY Change -46.9% -46.85% 47.35%
LONG-TERM ASSETS
Property, Plant & Equipment $70.37M $70.40M $75.60M
YoY Change -6.92% -6.88% -1.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $800.0K $800.0K $3.400M
YoY Change -76.47% -76.47% 0.0%
Total Long-Term Assets $71.17M $71.20M $79.02M
YoY Change -9.94% -9.87% -1.47%
TOTAL ASSETS
Total Short-Term Assets $17.68M $17.70M $33.30M
Total Long-Term Assets $71.17M $71.20M $79.02M
Total Assets $88.85M $88.90M $112.3M
YoY Change -20.9% -20.84% 9.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $700.0K $700.0K $2.600M
YoY Change -73.08% -73.08% -3.7%
Accrued Expenses $2.700M $2.700M $3.300M
YoY Change -18.18% -18.18% -26.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $25.90M
YoY Change -100.0% -100.0% 5080.0%
Total Short-Term Liabilities $11.19M $11.20M $34.70M
YoY Change -67.76% -67.72% 89.62%
LONG-TERM LIABILITIES
Long-Term Debt $14.00M $14.00M $8.200M
YoY Change 70.73% 70.73% -77.29%
Other Long-Term Liabilities $130.0K $100.0K $179.0K
YoY Change -27.37% -50.0% 21.77%
Total Long-Term Liabilities $130.0K $14.10M $179.0K
YoY Change -27.37% 67.86% 21.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.19M $11.20M $34.70M
Total Long-Term Liabilities $130.0K $14.10M $179.0K
Total Liabilities $25.32M $25.30M $43.06M
YoY Change -41.19% -41.3% -21.0%
SHAREHOLDERS EQUITY
Retained Earnings -$401.4M -$376.7M
YoY Change 6.54% 10.97%
Common Stock $11.00K $71.00K
YoY Change -84.51% -67.13%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $63.53M $63.50M $69.26M
YoY Change
Total Liabilities & Shareholders Equity $88.85M $88.90M $112.3M
YoY Change -20.9% -20.84% 9.23%

Cashflow Statement

Concept 2017 Q4 2017 2016 Q4
OPERATING ACTIVITIES
Net Income -$4.390M -$24.63M -$2.290M
YoY Change 91.7% -33.84% -71.23%
Depreciation, Depletion And Amortization $1.650M $6.640M $1.710M
YoY Change -3.51% -1.63% 2.4%
Cash From Operating Activities -$4.190M -$20.63M -$4.310M
YoY Change -2.78% 0.54% -39.72%
INVESTING ACTIVITIES
Capital Expenditures -$230.0K $1.906M -$420.0K
YoY Change -45.24% -67.9% -64.71%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$230.0K -$1.906M -$420.0K
YoY Change -45.24% -67.9% -64.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $11.04M
YoY Change -61.47%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.200M 3.587M 1.550M
YoY Change -22.58% -90.39% -83.1%
NET CHANGE
Cash From Operating Activities -4.190M -20.63M -4.310M
Cash From Investing Activities -230.0K -1.906M -420.0K
Cash From Financing Activities 1.200M 3.587M 1.550M
Net Change In Cash -3.220M -18.95M -3.180M
YoY Change 1.26% -274.5% -483.13%
FREE CASH FLOW
Cash From Operating Activities -$4.190M -$20.63M -$4.310M
Capital Expenditures -$230.0K $1.906M -$420.0K
Free Cash Flow -$3.960M -$22.53M -$3.890M
YoY Change 1.8% -14.82% -34.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
6193000
CY2016Q4 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
25769000
CY2017Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Liability
EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
5224000
CY2016Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2611000
CY2016Q4 gevo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
803000
CY2016Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
2698000
CY2016Q4 us-gaap Assets
Assets
112324000
CY2016Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
179000
CY2015 gevo Gain Loss From Change In Fair Value Of Senior Secured Convertible Debt
GainLossFromChangeInFairValueOfSeniorSecuredConvertibleDebt
3895000
CY2017 us-gaap Gross Profit
GrossProfit
-10629000
CY2017 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5182000
CY2015 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16692000
CY2016 us-gaap Operating Expenses
OperatingExpenses
14181000
CY2015 us-gaap Operating Expenses
OperatingExpenses
23302000
CY2017 us-gaap Operating Income Loss
OperatingIncomeLoss
-23282000
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-23985000
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-31927000
CY2017 us-gaap Interest Expense
InterestExpense
2951000
CY2016 us-gaap Interest Expense
InterestExpense
7837000
CY2015 us-gaap Interest Expense
InterestExpense
8243000
CY2017 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4933000
CY2016 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-763000
CY2015 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
232000
CY2016 gevo Gain Loss On Inducement Of Warrant Exercises
GainLossOnInducementOfWarrantExercises
-918000
CY2015 gevo Gain Loss On Inducement Of Warrant Exercises
GainLossOnInducementOfWarrantExercises
1775000
CY2017 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
1751000
CY2017 gevo Gain Loss From Change In Fair Value Of Warrant Liabilities
GainLossFromChangeInFairValueOfWarrantLiabilities
5101000
CY2016 gevo Gain Loss From Change In Fair Value Of Warrant Liabilities
GainLossFromChangeInFairValueOfWarrantLiabilities
1783000
CY2015 gevo Gain Loss From Change In Fair Value Of Warrant Liabilities
GainLossFromChangeInFairValueOfWarrantLiabilities
577000
CY2017 gevo Gain Loss From Change In Fair Value Of Senior Secured Convertible Debt
GainLossFromChangeInFairValueOfSeniorSecuredConvertibleDebt
-339000
CY2016 gevo Gain Loss From Change In Fair Value Of Senior Secured Convertible Debt
GainLossFromChangeInFairValueOfSeniorSecuredConvertibleDebt
-4204000
CY2016 gevo Gain Loss On Equity Issuance
GainLossOnEquityIssuance
-1519000
CY2015 gevo Gain Loss On Equity Issuance
GainLossOnEquityIssuance
-2523000
CY2017 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
23000
CY2016 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
215000
CY2015 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
20000
CY2017 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1348000
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13243000
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-4267000
CY2017 us-gaap Net Income Loss
NetIncomeLoss
-24630000
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-37228000
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-36194000
CY2017 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
9791000
CY2017 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1095000
CY2017 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
11044000
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28661000
CY2017 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3428950
CY2017 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
6198000
CY2017 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-16335000
CY2017 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.51
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-9.68
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-51.61
CY2017 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16295937
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3847421
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
701252
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
46964000
CY2015 gevo Issuance Of Common Stock Net Of Issue Costs And Warrants
IssuanceOfCommonStockNetOfIssueCostsAndWarrants
22446000
CY2015 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
3000
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2647000
CY2015 gevo Stock Issued During Period Value Upon Exercise Of Warrants
StockIssuedDuringPeriodValueUponExerciseOfWarrants
10166000
CY2015 gevo Issuance Of Common Stock Upon Conversion Of Debt
IssuanceOfCommonStockUponConversionOfDebt
714000
CY2015 gevo Issuance Of Common Stock Upon Exchange Of Debt
IssuanceOfCommonStockUponExchangeOfDebt
1580000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
48326000
CY2016 gevo Issuance Of Common Stock Net Of Issue Costs And Warrants
IssuanceOfCommonStockNetOfIssueCostsAndWarrants
34224000
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
886000
CY2016 gevo Stock Issued During Period Value Upon Exercise Of Warrants
StockIssuedDuringPeriodValueUponExerciseOfWarrants
12298000
CY2016 gevo Issuance Of Common Stock Upon Exchange Of Debt
IssuanceOfCommonStockUponExchangeOfDebt
10758000
CY2017 gevo Issuance Of Common Stock Net Of Issue Costs And Warrants
IssuanceOfCommonStockNetOfIssueCostsAndWarrants
6395000
CY2017 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
421000
CY2017 gevo Stock Issued During Period Value Upon Exercise Of Warrants
StockIssuedDuringPeriodValueUponExerciseOfWarrants
3429000
CY2017 gevo Issuance Of Common Stock Upon Exchange Of Debt
IssuanceOfCommonStockUponExchangeOfDebt
8652000
CY2017 gevo Gain Loss From Change In Fair Value Of Warrant Liabilities Net Of Exercises
GainLossFromChangeInFairValueOfWarrantLiabilitiesNetOfExercises
5101000
CY2016 gevo Gain Loss From Change In Fair Value Of Warrant Liabilities Net Of Exercises
GainLossFromChangeInFairValueOfWarrantLiabilitiesNetOfExercises
1783000
CY2015 gevo Gain Loss From Change In Fair Value Of Warrant Liabilities Net Of Exercises
GainLossFromChangeInFairValueOfWarrantLiabilitiesNetOfExercises
577000
CY2017 us-gaap Share Based Compensation
ShareBasedCompensation
421000
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
886000
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
2647000
CY2017 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6641000
CY2016 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6747000
CY2015 us-gaap Depreciation And Amortization
DepreciationAndAmortization
6573000
CY2017 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
962000
CY2016 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3977000
CY2015 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3772000
CY2016 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
1000
CY2015 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
7000
CY2017 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-68000
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-269000
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-970000
CY2017 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
904000
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-29000
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-805000
CY2017 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-137000
CY2016 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
119000
CY2015 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1000
CY2017 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1742000
CY2016 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-697000
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2771000
CY2017 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-20627000
CY2016 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-20516000
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-28160000
CY2017 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1906000
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5938000
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1464000
CY2015 gevo Proceeds From Sales Tax Refund For Property Plant And Equipment
ProceedsFromSalesTaxRefundForPropertyPlantAndEquipment
144000
CY2017 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1906000
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-5938000
CY2015 us-gaap Interest Paid
InterestPaid
4642000
CY2017 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
27000
CY2016 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
513000
CY2015 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
890000
CY2017 gevo Discount Due To Exchange Of Notes
DiscountDueToExchangeOfNotes
3009000
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1320000
CY2016 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
504000
CY2015 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
318000
CY2016 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
3144000
CY2015 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
3519000
CY2015 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
3000
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
33820000
CY2017 us-gaap Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
2611000
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
12298000
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
10166000
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
37311000
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
40152000
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10857000
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
10672000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17031000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6359000
CY2017 gevo Conversion And Exchanges Of Convertible Debt To Common Stock
ConversionAndExchangesOfConvertibleDebtToCommonStock
8652000
CY2016 gevo Conversion And Exchanges Of Convertible Debt To Common Stock
ConversionAndExchangesOfConvertibleDebtToCommonStock
10758000
CY2015 gevo Conversion And Exchanges Of Convertible Debt To Common Stock
ConversionAndExchangesOfConvertibleDebtToCommonStock
2294000
CY2017 us-gaap Interest Paid
InterestPaid
2554000
CY2016 us-gaap Interest Paid
InterestPaid
3694000
CY2017 gevo Fair Value Of Embedded Derivative Upon Exchange
FairValueOfEmbeddedDerivativeUponExchange
6975000
CY2015 gevo Accrued Offering Costs
AccruedOfferingCosts
648000
CY2017 gevo Fair Value Of Warrants At Issuance And Upon Exercise Net
FairValueOfWarrantsAtIssuanceAndUponExerciseNet
-4353000
CY2016 gevo Fair Value Of Warrants At Issuance And Upon Exercise Net
FairValueOfWarrantsAtIssuanceAndUponExerciseNet
6668000
CY2015 gevo Fair Value Of Warrants At Issuance And Upon Exercise Net
FairValueOfWarrantsAtIssuanceAndUponExerciseNet
-7951000
CY2016Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
218000
CY2017 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Use of Estimates<font style="font-style:normal;">. The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates. </font></p></div>
CY2017 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:12pt;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Concentrations of Credit Risk<font style="font-style:normal;">. The Company&#8217;s financial instruments that are exposed to concentrations of credit risk consist of cash and cash equivalents in excess of the federally insured limits. The Company&#8217;s cash and cash equivalents are deposited with high credit-quality financial institutions and are primarily in demand deposit accounts.</font></p></div>
CY2017 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36002965
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1210231
CY2016Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one-for-twenty
CY2016Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.05
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2016Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
107379000
CY2016Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
139315000
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1153445
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2922000
CY2017Q4 us-gaap Other Inventories Spare Parts
OtherInventoriesSpareParts
1405000
CY2016Q4 us-gaap Other Inventories Spare Parts
OtherInventoriesSpareParts
1349000
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
111640000
CY2016Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
110222000
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41271000
CY2016Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
34630000
CY2017 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
100000
CY2016 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
100000
CY2015 us-gaap Amortization Of Leased Asset
AmortizationOfLeasedAsset
100000
CY2017 us-gaap Cost Of Goods Sold Depreciation
CostOfGoodsSoldDepreciation
6200000
CY2017 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
6160000
CY2014Q2 gevo Percentage Of Aggregate Principal Amount Outstanding
PercentageOfAggregatePrincipalAmountOutstanding
0.10
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016 us-gaap Cost Of Goods Sold Depreciation
CostOfGoodsSoldDepreciation
6000000
CY2015 us-gaap Cost Of Goods Sold Depreciation
CostOfGoodsSoldDepreciation
5700000
CY2017Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
666000
CY2016Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
2611000
CY2017Q4 gevo Accrued Legal Related Expenses
AccruedLegalRelatedExpenses
274000
CY2016Q4 gevo Accrued Legal Related Expenses
AccruedLegalRelatedExpenses
626000
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
700000
CY2016Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1385000
CY2017Q4 us-gaap Interest Payable Current
InterestPayableCurrent
434000
CY2016Q4 us-gaap Interest Payable Current
InterestPayableCurrent
359000
CY2017Q4 gevo Accrued Production Fees
AccruedProductionFees
447000
CY2016Q4 gevo Accrued Production Fees
AccruedProductionFees
144000
CY2017Q4 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
677000
CY2016Q4 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
567000
CY2017Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
172000
CY2016Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
136000
CY2016Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
147000
CY2017Q4 us-gaap Customer Deposits Current
CustomerDepositsCurrent
436000
CY2017Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
205000
CY2017Q2 gevo Conversion Of Stock Price Exceeding Percentage
ConversionOfStockPriceExceedingPercentage
1.50
CY2017Q4 us-gaap Share Price
SharePrice
0.59
CY2017Q2 us-gaap Share Price
SharePrice
0.62
CY2017 gevo Debt Instrument Convertible Conversion Ratio Per One Thousand Dollars Principal Amount
DebtInstrumentConvertibleConversionRatioPerOneThousandDollarsPrincipalAmount
1358.90
CY2017Q2 gevo Debt Instrument Convertible Conversion Ratio Per One Thousand Dollars Principal Amount
DebtInstrumentConvertibleConversionRatioPerOneThousandDollarsPrincipalAmount
1358.90
CY2017Q4 gevo Conversion Price
ConversionPrice
0.74
CY2017Q2 gevo Conversion Price
ConversionPrice
0.74
CY2017 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2020-03-15
CY2017Q2 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2020-03-15
CY2017 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0189
CY2017Q2 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0145
CY2017 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.75
CY2017Q2 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.80
CY2017 us-gaap Fair Value Inputs Entity Credit Risk
FairValueInputsEntityCreditRisk
0.28
CY2017Q2 us-gaap Fair Value Inputs Entity Credit Risk
FairValueInputsEntityCreditRisk
0.28
CY2017Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Net
EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet
0
CY2016Q4 us-gaap Embedded Derivative Fair Value Of Embedded Derivative Net
EmbeddedDerivativeFairValueOfEmbeddedDerivativeNet
0
CY2017 gevo Warrants Issued To Purchase Additional Shares Of Common Stock
WarrantsIssuedToPurchaseAdditionalSharesOfCommonStock
17106683
CY2017Q4 gevo Common Shares Issued Upon Exercise Of Warrants
CommonSharesIssuedUponExerciseOfWarrants
9094310
CY2017Q4 gevo Shares Underlying Outstanding Warrants
SharesUnderlyingOutstandingWarrants
7192373
CY2017 us-gaap Common Stock Voting Rights
CommonStockVotingRights
The holders of the Company’s common stock have one vote per share.
CY2017 gevo Percentage Of Voting Power Required For Amendment
PercentageOfVotingPowerRequiredForAmendment
0.6667
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
886000
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2647000
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0149
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0162
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.0689
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M7D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M7D
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.0670
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.350
CY2017Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
100000
CY2017 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y
CY2017 us-gaap Deferred Compensation Arrangement With Individual Maximum Contractual Term1
DeferredCompensationArrangementWithIndividualMaximumContractualTerm1
P10Y
CY2017 gevo Tax Credit Carryforward Expiration Year
TaxCreditCarryforwardExpirationYear
2037
CY2017Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
100631000
CY2016Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
133514000
CY2017Q4 gevo Deferred Tax Assets Tax Credits
DeferredTaxAssetsTaxCredits
3482000
CY2016Q4 gevo Deferred Tax Assets Tax Credits
DeferredTaxAssetsTaxCredits
3482000
CY2017Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3266000
CY2016Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
2319000
CY2017Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
107379000
CY2016Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
139315000
CY2017Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.66
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
35.40
CY2017 gevo Share Based Compensation Options Estimated Forfeiture Rates Range Lower Limit
ShareBasedCompensationOptionsEstimatedForfeitureRatesRangeLowerLimit
0.00
CY2017 gevo Share Based Compensation Options Estimated Forfeiture Rates Range Upper Limit
ShareBasedCompensationOptionsEstimatedForfeitureRatesRangeUpperLimit
0.05
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16915
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
60000
CY2017 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
30484
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
46431
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
29013
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
46431
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
289.73
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.01
CY2017 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.01
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
106.19
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
165.47
CY2017Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
106.19
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y10M6D
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y3M
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2017 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.075
CY2016 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.029
CY2015 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.054
CY2017 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.000
CY2016 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.058
CY2015 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.012
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-1.838
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.000
CY2017 gevo Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.075
CY2016 gevo Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.180
CY2015 gevo Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.040
CY2017 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1.338
CY2016 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.141
CY2015 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.352
CY2017 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2016 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2015 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2017 gevo Defined Contribution Plan Service Period For Eligibility
DefinedContributionPlanServicePeriodForEligibility
P3M
CY2017 gevo Lease Term Expiration Period
LeaseTermExpirationPeriod
P12M
CY2017 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
CY2016 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1700000
CY2015 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
1600000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1421000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
907000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
394000
CY2017Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
200000
CY2017Q4 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
0
CY2017 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
2
CY2017 gevo Interest Expense Including Debt Issuance Costs
InterestExpenseIncludingDebtIssuanceCosts
2951000
CY2016 gevo Interest Expense Including Debt Issuance Costs
InterestExpenseIncludingDebtIssuanceCosts
7837000
CY2015 gevo Interest Expense Including Debt Issuance Costs
InterestExpenseIncludingDebtIssuanceCosts
8243000
CY2017 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
1906000
CY2016 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
5938000
CY2015 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
1464000
CY2017 gevo Intercompany Sales
IntercompanySales
400000
CY2016 gevo Intercompany Sales
IntercompanySales
200000

Files In Submission

Name View Source Status
0001564590-18-006978-index-headers.html Edgar Link pending
0001564590-18-006978-index.html Edgar Link pending
0001564590-18-006978.txt Edgar Link pending
0001564590-18-006978-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2018032820450556430173.jpg Edgar Link pending
gevo-10k_20171231.htm Edgar Link pending
gevo-20171231.xml Edgar Link completed
gevo-20171231.xsd Edgar Link pending
gevo-20171231_cal.xml Edgar Link unprocessable
gevo-20171231_def.xml Edgar Link unprocessable
gevo-20171231_lab.xml Edgar Link unprocessable
gevo-20171231_pre.xml Edgar Link unprocessable
gevo-ex1027_180.htm Edgar Link pending
gevo-ex1028_181.htm Edgar Link pending
gevo-ex231_10.htm Edgar Link pending
gevo-ex311_11.htm Edgar Link pending
gevo-ex312_9.htm Edgar Link pending
gevo-ex321_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending